| Trial ID: | L0089 |
| Source ID: | NCT04536636
|
| Associated Drug: |
Docohexanoic Acid
|
| Title: |
Docohexanoic Acid in Hemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Renal Failure
|
| Interventions: |
DRUG: Docohexanoic acid|DRUG: Control-No drug
|
| Outcome Measures: |
Primary: Determine correction of anemia, Determine correction of anemia measured by erythropoiesis-resistance index (ERI) to detect a difference of 10 units of response between groups at 8 weeks follow-up, with a SD of 10 and a power higher than 80%., Determine correction of anemia measured by erythropoiesis-resistance index (ERI) to detect a difference of 10 units of response between groups at 8 weeks follow-up, with a SD of 10 and a power higher than 80%. |
|
| Sponsor/Collaborators: |
Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
42
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2018-06-01
|
| Completion Date: |
2018-09-30
|
| Results First Posted: |
|
| Last Update Posted: |
2020-09-17
|
| Locations: |
Hospital Ramón y Cajal, Madrid, 28034, Spain
|
| URL: |
https://clinicaltrials.gov/show/NCT04536636
|
